Diltiazem gel 2% (DrugBank: Diltiazem)
3 diseasesID | Disease name (Link within this page) | Number of trials |
---|---|---|
51 | Scleroderma | 1 |
58 | Hypertrophic cardiomyopathy | 0 |
86 | Pulmonary arterial hypertension | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02801305 (ClinicalTrials.gov) | June 2016 | 9/6/2016 | Diltiazem Gel Versus Nitroglycerin Ointment in Healing Process of Scleroderma Digital Ulcers | Assessing and Comparing the Effect of Diltiazem Gel Versus Nitroglycerin Ointment in Healing Process of Scleroderma Digital Ulcers. | Digital Ulcer of Scleroderma | Drug: Diltiazem Gel 2%;Drug: Nitroglycerin Ointment 2%;Drug: Vaseline | Mohammad Ali Nazarinia | Shiraz University of Medical Sciences | Completed | 20 Years | 70 Years | All | 90 | Phase 2 | Iran, Islamic Republic of |